Injective is positioning its layer-1 blockchain as a specialized financial infrastructure, integrating native order books and tokenization tools directly into its base layer. While the platform has secured SEC-registered transfer agent status and supports institutional pilots with firms like BlackRock, it faces significant competition from Ethereum and Solana. As of October 2026, total supply remains at 122.9 million INJ, with cumulative issuance outpacing token burns.
Neutral
🤖 55%
This is an educational newsletter explaining Injective's architecture, tokenization push and burn mechanism, not news of a concrete event. Positive points (SEC-registered transfer agent status since August 2026, over 7 million INJ burned, BlackRock and Nomura-linked tokenized funds) are offset by the article's own caveats: total supply remains near 122.9 million, about 22.9% above launch, DeFi TVL of only about $18 million in October 2026, and competition from Ethereum and Solana. No new actionable catalyst for the coming days.
Risk Factors
- • Cumulative issuance has outpaced burns: supply near 122.9 million, roughly 22.9% above the 100 million issued at launch
- • DeFi total value locked only about $18 million as of October 2026